![Aoife Brennan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aoife Brennan
Directeur Général chez
CLIMB BIO, INC.
Fortune : 1 M $ au 31/07/2026
Profil
Dr. Aoife M.
Brennan, MD, is a President, Chief Executive Officer & Director at Climb Bio, Inc., an Independent Director at Xilio Therapeutics, Inc., a Chief Executive Officer at Lisney Ltd. and an Advisor at Atlas Venture Advisors, Inc. She is on the Board of Directors at Climb Bio, Inc., Xilio Therapeutics, Inc. and Cerevance, Inc. Dr. Brennan was previously employed as an Independent Director by FibroGen, Inc., an Independent Director by RA Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Synlogic Operating Co., Inc., a President, Chief Executive Officer & Director by Synlogic, Inc., a Vice President & Head-Rare Disease Innovation Unit by Biogen, Inc., and a Director-Clinical Development by Tolerx, Inc. She received her undergraduate degree from Technological University Dublin, a graduate degree from Technological University Dublin, a graduate degree from Harvard Medical School and a doctorate degree from Trinity College Dublin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLIMB BIO, INC. 0,15% | 29/06/2026 | 87 731 ( 0,15% ) | 1 M $ | 31/07/2026 |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Aoife Brennan
| Sociétés | Poste | Début |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/06/2024 |
| CLIMB BIO, INC. | Directeur Général | 27/06/2024 |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Directeur/Membre du Conseil | 01/01/2020 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Lisney Ltd.
 Lisney Ltd. Real Estate DevelopmentFinance Provides property consultancy services | Directeur Général | 18/03/2026 |
Anciens postes connus de Aoife Brennan
| Sociétés | Poste | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Directeur/Membre du Conseil | 04/06/2025 |
| SYNLOGIC, INC. | Directeur Général | 09/03/2024 |
| RA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/04/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/08/2016 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Aoife Brennan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lisney Ltd.
Lisney Ltd. Real Estate DevelopmentFinance Provides property consultancy services | Finance |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Technological University Dublin
 Technological University Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
